Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Immunocore Holdings Plc ADR (NQ: IMCR )

30.99 +0.22 (+0.71%)
Streaming Delayed Price Updated: 9:30 AM EDT, Sep 27, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Immunocore Holdings Plc ADR

< Previous 1 2 3 4 5 6 Next >
Immunocore Hldgs's Earnings: A Preview
Via Benzinga
Immunocore announces clinical trial collaboration and supply agreement with Bristol Myers Squibb to evaluate IMC-F106C (PRAME HLA-A02) in combination with nivolumab in its registrational Phase 3 first-line advanced cutaneous melanoma trial
From Immunocore Holdings Limited
Via GlobeNewswire
Immunocore to report fourth quarter and full year 2023 financial results and host call on February 28, 2024
From Immunocore Holdings Limited
Via GlobeNewswire
Immunocore Prices Upsized Convertible Senior Notes Offering
From Immunocore Holdings Limited
Via GlobeNewswire
Immunocore's Pipeline Is Among The Strongest In Broader Biotech Universe: Analyst
H.C. Wainwright analyst Patrick R. 
Via Benzinga
5 Analysts Have This to Say About Immunocore Hldgs
Via Benzinga
Analyst Ratings for Immunocore Hldgs
Via Benzinga
Analyst Expectations for Immunocore Hldgs's Future
Via Benzinga
Immunocore Announces Proposed Convertible Senior Notes Offering
From Immunocore Holdings Limited
Via GlobeNewswire
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Why Applied Therapeutics Shares Are Trading Lower By Over 35%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Shares of Applied Therapeutics, Inc. 
Via Benzinga
Where Immunocore Hldgs Stands With Analysts
Via Benzinga
Immunocore Hldgs's Earnings Outlook
Via Benzinga
Immunocore announces strategic priorities and pipeline expansion ahead of 42nd Annual J.P. Morgan Healthcare Conference presentation
From Immunocore Holdings Limited
Via GlobeNewswire
Immunocore to present at the 42nd Annual J.P. Morgan Healthcare Conference
From Immunocore Holdings Limited
Via GlobeNewswire
AGC Biologics to Prepare Late Phase and Commercial Runs for Immunocore
--News Direct-- 
Via News Direct
Immunocore Reports Third Quarter 2023 Financial Results and Provides Business Update
From Immunocore Holdings Limited
Via GlobeNewswire
Immunocore announces upcoming poster presentations at SITC Annual Meeting 2023 and SMR Congress 2023
From Immunocore Holdings Limited
Via GlobeNewswire
Immunocore to present at upcoming investor conferences
From Immunocore Holdings Limited
Via GlobeNewswire
Immunocore presents three-year overall survival data from the KIMMTRAK Phase 3 trial
From Immunocore Holdings Limited
Via GlobeNewswire
Immunocore announces upcoming presentation and posters at ESMO 2023
From Immunocore Holdings Limited
Via GlobeNewswire
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Cancer Focused Immunocore Leads The Way In TCR Therapeutics, Positioned For Success: Analyst Says
Needham has initiated coverage on Immunocore Holdings Plc (NASDAQ: IMCR) with a Buy rating and  
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 13, 2023
Via Benzinga
Immunocore to present at upcoming investor conferences
From Immunocore Holdings Limited
Via GlobeNewswire
Institutions are Buying These 3 Stocks and Analysts Agree
Rumble (RUM), Immunocore (IMCR), and STMicroelectronics (STM) are attracting increased institutional interest, presenting potential investment opportunities. 
Via MarketBeat
Immunocore to present at upcoming investor conferences
From Immunocore Holdings Limited
Via GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For August 16, 2023
Via Benzinga
Immunocore Reports Second Quarter 2023 Financial Results and Provides Business Update
From Immunocore Holdings Limited
Via GlobeNewswire
Immunocore to report second quarter 2023 financial results and host call on August 10, 2023
From Immunocore Holdings Limited
Via GlobeNewswire
< Previous 1 2 3 4 5 6 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.